Login to Your Account



Removing regulatory hurdles

Budget increases FDA spending, reflects NIH lessons learned

By Mari Serebrov
Regulatory Editor

Wednesday, February 14, 2018

Consider it the fulfillment of President Donald Trump's campaign promise to bring down drug prices in the U.S. That's how White House Budget Director Mick Mulvaney framed the administration's proposal to give the FDA a hefty spending hike in fiscal 2019 through user fees and tax dollars.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription